Share Price and Basic Stock Data
Last Updated: December 12, 2025, 4:11 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Capital India Finance Ltd operates in the competitive Non-Banking Financial Company (NBFC) sector, where it has carved a niche for itself. The company reported a revenue of ₹655 Cr for FY 2023, which marked a steady increase from ₹532 Cr in FY 2022. However, the revenue dipped slightly to ₹612 Cr in FY 2025, indicating potential headwinds. Quarter-on-quarter, the sales figures have shown variability; notably, Q2 FY 2024 saw a modest recovery with sales at ₹165.94 Cr, up from ₹159.40 Cr in Q1. This oscillation in sales suggests that while the company is capable of generating growth, it faces challenges in maintaining consistent momentum. The latest quarterly figure of ₹176.11 Cr in Q3 FY 2024 suggests that the company may be regaining its footing, and it will be crucial to monitor if this trend continues.
Profitability and Efficiency Metrics
Profitability remains a significant concern for Capital India Finance, as evidenced by its reported net profit of -₹10 Cr for FY 2025. This follows a troubling trend, with the company posting losses of ₹87 Cr in FY 2023 and ₹21 Cr in FY 2022. The operating profit margin (OPM) appears stronger in recent quarters, stabilizing at 22.18% by March 2025, a commendable recovery from the lows of 3% seen in FY 2023. However, the interest coverage ratio stands at a precarious 1.22x, which indicates that the company is just about covering its interest obligations, raising concerns about its long-term sustainability. The variability in operating profit, which peaked at ₹118 Cr in FY 2024, underscores the need for improved operational efficiency and cost management to enhance profitability further.
Balance Sheet Strength and Financial Ratios
Capital India Finance’s balance sheet reveals a mixed picture. The company reported total borrowings of ₹700 Cr, a significant increase from ₹764 Cr in FY 2022, showing a reliance on debt to fuel its operations. The current ratio of 1.46x suggests that the company can cover its short-term liabilities, which appears comfortable. However, the debt-to-equity ratio of 1.55x raises eyebrows, indicating that the company is heavily leveraged compared to its equity base. The reported reserves of ₹594 Cr provide some cushion, but the declining trend in retained earnings is concerning. With a price-to-book value (P/BV) ratio of 1.89x, the stock seems fairly valued, but investors should be cautious about the implications of high debt levels on future profitability and growth.
Shareholding Pattern and Investor Confidence
The shareholding structure of Capital India Finance reveals a strong promoter backing, with promoters holding 72.84% of the company. This high level of insider ownership typically signals confidence in the company’s long-term prospects. However, foreign institutional investors (FIIs) account for a mere 0.08%, suggesting a lack of external confidence in the stock. The increase in the number of public shareholders from 1,262 in December 2022 to 7,056 by March 2025 indicates growing interest from retail investors, which could be a positive sign for liquidity and market perception. However, the absence of institutional backing may pose challenges in terms of stock stability during market fluctuations, as retail investors often lack the same level of commitment during downturns.
Outlook, Risks, and Final Insight
Looking ahead, Capital India Finance faces a mixed outlook. On one hand, the recovery in operating profit margins and an increasing number of shareholders can be seen as positive indicators. On the other hand, the persistent net losses and reliance on debt present significant risks. The company must focus on enhancing operational efficiencies and managing costs more effectively to return to profitability. Additionally, the low institutional interest could lead to volatility, especially if market conditions sour. Investors should consider these factors carefully; while the potential for growth exists, the inherent risks associated with high leverage and inconsistent profitability cannot be overlooked. A prudent approach would be to monitor the company’s ability to stabilize its earnings and improve its balance sheet health before making substantial investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Capital India Finance Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 12.1 Cr. | 1.21 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 9.33 Cr. | 0.93 | 9.18/0.85 | 27.4 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 436 Cr. | 133 | 269/126 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.6 Cr. | 17.0 | 34.4/15.0 | 11.6 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 38.3 Cr. | 85.2 | 165/74.8 | 20.5 | 238 | 1.17 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,825.22 Cr | 440.63 | 50.24 | 522.84 | 0.23% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152.57 | 158.87 | 169.27 | 161.79 | 159.74 | 174.99 | 176.11 | 165.12 | 167.38 | 159.40 | 165.94 | 152.93 | 139.33 |
| Expenses | 133.94 | 158.83 | 162.00 | 160.15 | 155.99 | 146.23 | 146.90 | 133.99 | 139.98 | 134.00 | 131.49 | 118.40 | 108.43 |
| Operating Profit | 18.63 | 0.04 | 7.27 | 1.64 | 3.75 | 28.76 | 29.21 | 31.13 | 27.40 | 25.40 | 34.45 | 34.53 | 30.90 |
| OPM % | 12.21% | 0.03% | 4.29% | 1.01% | 2.35% | 16.44% | 16.59% | 18.85% | 16.37% | 15.93% | 20.76% | 22.58% | 22.18% |
| Other Income | 1.89 | 2.00 | 1.59 | 1.98 | 1.69 | 11.47 | 2.47 | 0.66 | 2.42 | 0.70 | 1.33 | 0.44 | 2.00 |
| Interest | 16.42 | 19.06 | 18.68 | 20.85 | 22.04 | 25.74 | 26.24 | 25.30 | 24.77 | 25.69 | 25.41 | 27.74 | 27.88 |
| Depreciation | 5.85 | 5.89 | 6.30 | 6.43 | 6.15 | 7.31 | 7.96 | 7.64 | 7.26 | 7.92 | 7.92 | 8.15 | 7.94 |
| Profit before tax | -1.75 | -22.91 | -16.12 | -23.66 | -22.75 | 7.18 | -2.52 | -1.15 | -2.21 | -7.51 | 2.45 | -0.92 | -2.92 |
| Tax % | -85.71% | 2.66% | 11.35% | -8.37% | 5.23% | 32.45% | 102.78% | 105.22% | 71.95% | -15.45% | 75.51% | 107.61% | -11.99% |
| Net Profit | -0.25 | -23.51 | -17.95 | -21.68 | -23.94 | 4.85 | -5.11 | -2.37 | -3.80 | -6.35 | 0.60 | -1.91 | -2.56 |
| EPS in Rs | 0.06 | -0.32 | -0.20 | -0.25 | -0.30 | 0.27 | 0.00 | 0.01 | 0.02 | -0.04 | 0.08 | 0.02 | -0.02 |
Last Updated: May 31, 2025, 6:36 am
Below is a detailed analysis of the quarterly data for Capital India Finance Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 139.33 Cr.. The value appears to be declining and may need further review. It has decreased from 152.93 Cr. (Dec 2024) to 139.33 Cr., marking a decrease of 13.60 Cr..
- For Expenses, as of Mar 2025, the value is 108.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 118.40 Cr. (Dec 2024) to 108.43 Cr., marking a decrease of 9.97 Cr..
- For Operating Profit, as of Mar 2025, the value is 30.90 Cr.. The value appears to be declining and may need further review. It has decreased from 34.53 Cr. (Dec 2024) to 30.90 Cr., marking a decrease of 3.63 Cr..
- For OPM %, as of Mar 2025, the value is 22.18%. The value appears to be declining and may need further review. It has decreased from 22.58% (Dec 2024) to 22.18%, marking a decrease of 0.40%.
- For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.44 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.56 Cr..
- For Interest, as of Mar 2025, the value is 27.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.74 Cr. (Dec 2024) to 27.88 Cr., marking an increase of 0.14 Cr..
- For Depreciation, as of Mar 2025, the value is 7.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.15 Cr. (Dec 2024) to 7.94 Cr., marking a decrease of 0.21 Cr..
- For Profit before tax, as of Mar 2025, the value is -2.92 Cr.. The value appears to be declining and may need further review. It has decreased from -0.92 Cr. (Dec 2024) to -2.92 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Mar 2025, the value is -11.99%. The value appears to be improving (decreasing) as expected. It has decreased from 107.61% (Dec 2024) to -11.99%, marking a decrease of 119.60%.
- For Net Profit, as of Mar 2025, the value is -2.56 Cr.. The value appears to be declining and may need further review. It has decreased from -1.91 Cr. (Dec 2024) to -2.56 Cr., marking a decrease of 0.65 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.02. The value appears to be declining and may need further review. It has decreased from 0.02 (Dec 2024) to -0.02, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:42 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 26 | 60 | 179 | 318 | 532 | 655 | 680 | 612 | 598 |
| Expenses | 11 | 31 | 127 | 265 | 476 | 633 | 562 | 485 | 467 |
| Operating Profit | 15 | 28 | 53 | 54 | 56 | 22 | 118 | 127 | 131 |
| OPM % | 58% | 47% | 29% | 17% | 11% | 3% | 17% | 21% | 22% |
| Other Income | 0 | 0 | 0 | -0 | -2 | 1 | 18 | 6 | 4 |
| Interest | 10 | 9 | 17 | 24 | 51 | 84 | 105 | 110 | 109 |
| Depreciation | 0 | 8 | 12 | 15 | 21 | 25 | 30 | 32 | 32 |
| Profit before tax | 4 | 11 | 24 | 15 | -18 | -85 | 1 | -9 | -6 |
| Tax % | 37% | 42% | 43% | 59% | 18% | 2% | 599% | 15% | |
| Net Profit | 3 | 7 | 14 | 6 | -21 | -87 | -6 | -10 | -10 |
| EPS in Rs | 0.89 | 0.17 | 0.44 | 0.25 | -0.07 | -1.07 | 0.30 | 0.04 | 0.01 |
| Dividend Payout % | 13% | 48% | 5% | 8% | -28% | -2% | 7% | 50% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 100.00% | -57.14% | -450.00% | -314.29% | 93.10% | -66.67% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.33% | -157.14% | -392.86% | 135.71% | 407.39% | -159.77% |
Capital India Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 5% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -38% |
| 3 Years: | 37% |
| TTM: | 178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| 1 Year: | 34% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:35 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 78 | 78 | 78 | 78 | 78 | 78 | 78 | 78 |
| Reserves | 128 | 430 | 444 | 485 | 543 | 528 | 545 | 550 | 594 |
| Borrowings | 7 | 132 | 121 | 327 | 764 | 924 | 899 | 996 | 700 |
| Other Liabilities | 16 | 30 | 70 | 154 | 242 | 265 | 279 | 228 | 229 |
| Total Liabilities | 154 | 670 | 713 | 1,044 | 1,626 | 1,795 | 1,801 | 1,853 | 1,601 |
| Fixed Assets | 8 | 31 | 47 | 56 | 78 | 81 | 94 | 90 | 83 |
| CWIP | 2 | 2 | 1 | 5 | 11 | 35 | 10 | 9 | 0 |
| Investments | 0 | 24 | 9 | 0 | 10 | 44 | 10 | 64 | 197 |
| Other Assets | 144 | 614 | 656 | 982 | 1,528 | 1,634 | 1,687 | 1,691 | 1,321 |
| Total Assets | 154 | 670 | 713 | 1,044 | 1,626 | 1,795 | 1,801 | 1,853 | 1,601 |
Below is a detailed analysis of the balance sheet data for Capital India Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 78.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 78.00 Cr..
- For Reserves, as of Sep 2025, the value is 594.00 Cr.. The value appears strong and on an upward trend. It has increased from 550.00 Cr. (Mar 2025) to 594.00 Cr., marking an increase of 44.00 Cr..
- For Borrowings, as of Sep 2025, the value is 700.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 996.00 Cr. (Mar 2025) to 700.00 Cr., marking a decrease of 296.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 229.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 228.00 Cr. (Mar 2025) to 229.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,601.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,853.00 Cr. (Mar 2025) to 1,601.00 Cr., marking a decrease of 252.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 197.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 197.00 Cr., marking an increase of 133.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,321.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,691.00 Cr. (Mar 2025) to 1,321.00 Cr., marking a decrease of 370.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,601.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,853.00 Cr. (Mar 2025) to 1,601.00 Cr., marking a decrease of 252.00 Cr..
However, the Borrowings (700.00 Cr.) are higher than the Reserves (594.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | -104.00 | -68.00 | -273.00 | -708.00 | -902.00 | -781.00 | -869.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4 | 0 | 1 | 8 | 6 | 10 | 4 | 7 |
| Inventory Days | ||||||||
| Days Payable | ||||||||
| Cash Conversion Cycle | 4 | 0 | 1 | 8 | 6 | 10 | 4 | 7 |
| Working Capital Days | 1,176 | -69 | -101 | -65 | -73 | -79 | -80 | -54 |
| ROCE % | 5% | 6% | 5% | 3% | -0% | 6% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.04 | 1.50 | -5.35 | -0.36 | 1.24 |
| Diluted EPS (Rs.) | 0.04 | 1.48 | -5.32 | -0.35 | 1.22 |
| Cash EPS (Rs.) | 0.55 | 3.05 | -6.78 | 0.05 | 2.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.14 | 80.10 | 84.43 | 89.27 | 76.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.14 | 80.10 | 84.43 | 89.27 | 76.74 |
| Revenue From Operations / Share (Rs.) | 15.79 | 87.49 | 83.58 | 68.17 | 74.55 |
| PBDIT / Share (Rs.) | 3.33 | 15.85 | 3.80 | 7.04 | 6.90 |
| PBIT / Share (Rs.) | 2.51 | 11.97 | 0.61 | 4.35 | 5.02 |
| PBT / Share (Rs.) | -0.22 | 0.16 | -9.75 | -2.23 | 1.90 |
| Net Profit / Share (Rs.) | -0.26 | -0.82 | -9.96 | -2.63 | 0.78 |
| NP After MI And SOA / Share (Rs.) | 0.03 | 1.50 | -5.35 | -0.35 | 1.24 |
| PBDIT Margin (%) | 21.11 | 18.11 | 4.55 | 10.32 | 9.25 |
| PBIT Margin (%) | 15.91 | 13.67 | 0.74 | 6.37 | 6.73 |
| PBT Margin (%) | -1.44 | 0.19 | -11.67 | -3.27 | 2.54 |
| Net Profit Margin (%) | -1.66 | -0.94 | -11.92 | -3.86 | 1.05 |
| NP After MI And SOA Margin (%) | 0.25 | 1.71 | -6.39 | -0.52 | 1.65 |
| Return on Networth / Equity (%) | 0.24 | 1.87 | -6.86 | -0.44 | 1.70 |
| Return on Capital Employeed (%) | 14.47 | 13.54 | 0.63 | 4.04 | 5.36 |
| Return On Assets (%) | 0.08 | 0.64 | -2.31 | -0.17 | 0.92 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.13 | 0.19 | 0.20 |
| Total Debt / Equity (X) | 1.55 | 1.42 | 1.48 | 1.17 | 0.51 |
| Asset Turnover Ratio (%) | 0.33 | 0.37 | 0.11 | 0.10 | 0.46 |
| Current Ratio (X) | 1.46 | 1.49 | 1.58 | 1.89 | 3.05 |
| Quick Ratio (X) | 1.46 | 1.49 | 1.58 | 1.89 | 3.04 |
| Inventory Turnover Ratio (X) | 590.24 | 1.46 | 0.00 | 0.00 | 4517.32 |
| Dividend Payout Ratio (NP) (%) | 50.22 | 6.67 | -1.86 | -28.07 | 8.09 |
| Dividend Payout Ratio (CP) (%) | 2.32 | 1.85 | -4.62 | 4.28 | 3.20 |
| Earning Retention Ratio (%) | 49.78 | 93.33 | 101.86 | 128.07 | 91.91 |
| Cash Earning Retention Ratio (%) | 97.68 | 98.15 | 104.62 | 95.72 | 96.80 |
| Interest Coverage Ratio (X) | 1.22 | 1.21 | 0.36 | 1.07 | 2.21 |
| Interest Coverage Ratio (Post Tax) (X) | 0.90 | 0.83 | 0.03 | 0.59 | 1.25 |
| Enterprise Value (Cr.) | 1911.81 | 1607.41 | 1335.02 | 1420.77 | 1220.36 |
| EV / Net Operating Revenue (X) | 3.11 | 2.36 | 2.05 | 2.68 | 2.11 |
| EV / EBITDA (X) | 14.73 | 13.05 | 45.14 | 25.97 | 22.74 |
| MarketCap / Net Operating Revenue (X) | 1.93 | 1.51 | 1.08 | 1.83 | 1.94 |
| Retention Ratios (%) | 49.77 | 93.32 | 101.86 | 128.07 | 91.90 |
| Price / BV (X) | 1.89 | 1.65 | 1.16 | 1.56 | 2.00 |
| Price / Net Operating Revenue (X) | 1.93 | 1.51 | 1.08 | 1.83 | 1.94 |
| EarningsYield | 0.00 | 0.01 | -0.05 | 0.00 | 0.01 |
After reviewing the key financial ratios for Capital India Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 2.00, marking a decrease of 8.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 1.50 (Mar 24) to 0.04, marking a decrease of 1.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 1.48 (Mar 24) to 0.04, marking a decrease of 1.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 3. It has decreased from 3.05 (Mar 24) to 0.55, marking a decrease of 2.50.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.14. It has decreased from 80.10 (Mar 24) to 16.14, marking a decrease of 63.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 16.14. It has decreased from 80.10 (Mar 24) to 16.14, marking a decrease of 63.96.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 15.79. It has decreased from 87.49 (Mar 24) to 15.79, marking a decrease of 71.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.33. This value is within the healthy range. It has decreased from 15.85 (Mar 24) to 3.33, marking a decrease of 12.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.51. This value is within the healthy range. It has decreased from 11.97 (Mar 24) to 2.51, marking a decrease of 9.46.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.22. This value is below the healthy minimum of 0. It has decreased from 0.16 (Mar 24) to -0.22, marking a decrease of 0.38.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.26. This value is below the healthy minimum of 2. It has increased from -0.82 (Mar 24) to -0.26, marking an increase of 0.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 1.50 (Mar 24) to 0.03, marking a decrease of 1.47.
- For PBDIT Margin (%), as of Mar 25, the value is 21.11. This value is within the healthy range. It has increased from 18.11 (Mar 24) to 21.11, marking an increase of 3.00.
- For PBIT Margin (%), as of Mar 25, the value is 15.91. This value is within the healthy range. It has increased from 13.67 (Mar 24) to 15.91, marking an increase of 2.24.
- For PBT Margin (%), as of Mar 25, the value is -1.44. This value is below the healthy minimum of 10. It has decreased from 0.19 (Mar 24) to -1.44, marking a decrease of 1.63.
- For Net Profit Margin (%), as of Mar 25, the value is -1.66. This value is below the healthy minimum of 5. It has decreased from -0.94 (Mar 24) to -1.66, marking a decrease of 0.72.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 8. It has decreased from 1.71 (Mar 24) to 0.25, marking a decrease of 1.46.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 15. It has decreased from 1.87 (Mar 24) to 0.24, marking a decrease of 1.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.47. This value is within the healthy range. It has increased from 13.54 (Mar 24) to 14.47, marking an increase of 0.93.
- For Return On Assets (%), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 24) to 0.08, marking a decrease of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.55. This value exceeds the healthy maximum of 1. It has increased from 1.42 (Mar 24) to 1.55, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.37 (Mar 24) to 0.33, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 1.5. It has decreased from 1.49 (Mar 24) to 1.46, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 1.49 (Mar 24) to 1.46, marking a decrease of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 590.24. This value exceeds the healthy maximum of 8. It has increased from 1.46 (Mar 24) to 590.24, marking an increase of 588.78.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 50.22. This value exceeds the healthy maximum of 50. It has increased from 6.67 (Mar 24) to 50.22, marking an increase of 43.55.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 20. It has increased from 1.85 (Mar 24) to 2.32, marking an increase of 0.47.
- For Earning Retention Ratio (%), as of Mar 25, the value is 49.78. This value is within the healthy range. It has decreased from 93.33 (Mar 24) to 49.78, marking a decrease of 43.55.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.68. This value exceeds the healthy maximum of 70. It has decreased from 98.15 (Mar 24) to 97.68, marking a decrease of 0.47.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 3. It has increased from 1.21 (Mar 24) to 1.22, marking an increase of 0.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 3. It has increased from 0.83 (Mar 24) to 0.90, marking an increase of 0.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,911.81. It has increased from 1,607.41 (Mar 24) to 1,911.81, marking an increase of 304.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.11. This value exceeds the healthy maximum of 3. It has increased from 2.36 (Mar 24) to 3.11, marking an increase of 0.75.
- For EV / EBITDA (X), as of Mar 25, the value is 14.73. This value is within the healthy range. It has increased from 13.05 (Mar 24) to 14.73, marking an increase of 1.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.93, marking an increase of 0.42.
- For Retention Ratios (%), as of Mar 25, the value is 49.77. This value is within the healthy range. It has decreased from 93.32 (Mar 24) to 49.77, marking a decrease of 43.55.
- For Price / BV (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 1.89, marking an increase of 0.24.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.93, marking an increase of 0.42.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Capital India Finance Ltd:
- Net Profit Margin: -1.66%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.47% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.24% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 50.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -1.66%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 701, 7th Floor, Aggarwal Corporate Tower, Plot No. 23, District Centre, Rajendra Place, New Delhi Delhi 110008 | secretarial@capitalindia.com http://www.capitalindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Somani | Non Exe.Chairman&Ind.Director |
| Mr. Keshav Porwal | Managing Director |
| Mr. Yogendra Pal Singh | Independent Director |
| Mr. Dalbir Singh Suhag | Independent Director |
| Ms. Rashmi Fauzdar | Independent Woman Director |
| Ms. Jyuthika Mahendra Jivani | Independent Woman Director |
FAQ
What is the intrinsic value of Capital India Finance Ltd?
Capital India Finance Ltd's intrinsic value (as of 12 December 2025) is 0.62 which is 98.23% lower the current market price of 35.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,369 Cr. market cap, FY2025-2026 high/low of 44.5/29.0, reserves of ₹594 Cr, and liabilities of 1,601 Cr.
What is the Market Cap of Capital India Finance Ltd?
The Market Cap of Capital India Finance Ltd is 1,369 Cr..
What is the current Stock Price of Capital India Finance Ltd as on 12 December 2025?
The current stock price of Capital India Finance Ltd as on 12 December 2025 is 35.1.
What is the High / Low of Capital India Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Capital India Finance Ltd stocks is 44.5/29.0.
What is the Stock P/E of Capital India Finance Ltd?
The Stock P/E of Capital India Finance Ltd is .
What is the Book Value of Capital India Finance Ltd?
The Book Value of Capital India Finance Ltd is 17.2.
What is the Dividend Yield of Capital India Finance Ltd?
The Dividend Yield of Capital India Finance Ltd is 0.06 %.
What is the ROCE of Capital India Finance Ltd?
The ROCE of Capital India Finance Ltd is 6.34 %.
What is the ROE of Capital India Finance Ltd?
The ROE of Capital India Finance Ltd is 0.30 %.
What is the Face Value of Capital India Finance Ltd?
The Face Value of Capital India Finance Ltd is 2.00.